Play Video
How to get a test ?
Medicare part B now covers this test for qualifying patients. We will mail a self-saliva test kit upon checking and verifying your eligibility.
Program Eligibility : Symptomatic individual 65 years or older with clinical diagnosis or suspicion of one of the following conditions:
- Amyotrophic lateral sclerosis (ALS)
- Parkinson disease (PD)
- Frontotemporal dementia (FTD)
- Alzheimer disease with onset <65 years of age
- Hereditary prion disease
Genetic testing can help
- Confirm a suspected diagnosis
- Provide treatment guidance
- Support enrollment in precision therapy clinical trials
- Determine which relatives may be at risk
Don’t wait! Click here to sign up.
*** Registering will allow us to send you information and updates via text message and email. You can unsubscribe anytime by replying STOP or UNSUBSCRIBE.
How to get a test ?
Medicare part B now covers this test for qualifying patients. We will mail a self-saliva test kit upon checking and verifying your eligibility.
Program Eligibility : Symptomatic individual 65 years or older with clinical diagnosis or suspicion of one of the following conditions:
- Amyotrophic lateral sclerosis (ALS)
- Parkinson disease (PD)
- Frontotemporal dementia (FTD) ▪
- Alzheimer disease with onset <65 years of age
- Hereditary prion disease
Genetic testing can help
- Confirm a suspected diagnosis
- Provide treatment guidance
- Support enrollment in precision therapy clinical trials
- Determine which relatives may be at risk
Don’t wait! Click here to sign up.
*** Registering will allow us to send you information and updates via text message and email. You can unsubscribe anytime by replying STOP or UNSUBSCRIBE.
What is
Neurodegenerative Disease
Advances in genetic testing for neurodegenerative conditions have improved the ability to make accurate diagnoses, provide recurrence risk information to family members, and (in some cases) determine eligibility for clinical trials. A number of neurodegenerative conditions have an underlying genetic cause, with a 50% recurrence risk when inheritance is autosomal dominant.
The diagnosis of a neurodegenerative condition can therefore have implications not only for the affected individual, but also for relatives, who may be simultaneously watching a loved one’s decline and contemplating their own at-risk status.
The diagnosis of a neurodegenerative condition can therefore have implications not only for the affected individual, but also for relatives, who may be simultaneously watching a loved one’s decline and contemplating their own at-risk status.
Abstract
Advances in genomic science are informing an expansion of genetic testing for neurodegenerative diseases, which can be used for diagnostic and predictive purposes and performed in both medical and consumer genomics settings. Such testing—which is often for severe and incurable conditions like Huntington’s, Alzheimer’s, and Parkinson’s diseases—raises important communication challenges.
Neurocognitive Diseases
Evaluation Panel
Comprehensive Neurocognitive Genetics Panel
Detect 64 risk factors associated with neurocognitive disorder
Symptoms of
Neurodegenerative Disease
- Depression
- Anxiety
- Fatigue
- Insomnia
- Sleep disorder
- Tremor
- Gait disturbance
- Repeated falls
- Amnesia
- Hallucinations
- Speech disturbance
- Agitation
Conditions of
Neurodegenerative Disease
- Dementia
- Vascular dementia
- Cerebellar ataxia
- ALS
- Parkinson's
- Alzheimer's
- Frontotemporal lobe dementia
- Lewy Body dementia
